Filing Details

Accession Number:
0001209191-10-054315
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-10 18:42:48
Reporting Period:
2010-11-10
Filing Date:
2010-11-10
Accepted Time:
2010-11-10 18:42:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
861838 Idera Pharmaceuticals Inc. IDRA Biological Products, (No Disgnostic Substances) (2836) 043072298
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192994 Keith C Hartley 14 Wynnwood Road
Greenwich CT 06830-3409
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-10 7,000 $2.79 51,184 No 4 P Direct
Common Stock Acquisiton 2010-11-10 3,000 $2.80 54,184 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.78 to $2.80, inclusive. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of such issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  2. Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.78 to $2.80, inclusive.